Search »
- Use quotation marks (e.g., "RSR Manual") to search for exact phrases.
- You must be logged in to search for people in the Ryan White/TargetHIV community.
Content type
Topic Areas
Source
Publication Date
-
Doxycycline that is taken as post-exposure prophylaxis (PEP) is effective in reducing the incidence of chlamydia and gonorrhea in men who have sex with men and transgender women.News Article updated on 04/11/2023
-
Health Centers on the Front Lines Podcast: Status Neutral
Review of concept of status neutral (access to HIV services regardless of HIV status).Resource updated 10/24/2023
-
Health Centers on the Front Lines Podcast: Get to know! Long-Acting injectable PrEP and HIV treatment
In 2021, the U.S. public was introduced to a bi-monthly injectable form of PrEP, which stands for Pre-Exposure Prophylaxis.Resource updated 05/11/2023
-
Micro Learning: Get to know! Long-Acting Injectable PrEP and HIV Treatment
Review of types of injectable long lasting HIV prevention and treatment medications and their similarities and differences.Resource updated 12/19/2023
-
Health Centers on the Front Lines: Be the Change: Black Cisgender and Trans Women, HIV Treatment, & PrEP
Role of health centers in increasing PrEP access and use among women.Resource updated 10/18/2023
-
Micro Learning: Black Cisgender and Trans Women, HIV Treatment, & PrEP
Learn how to improve messaging about HIV prevention and care to improve acceptance of services among all Black women.Resource updated 05/10/2023
-
Medical Home for Multiply Diagnosed HIV-Positive Homeless Populations
The RWHAP Part F SPNS program funded the Building a Medical Home for Multiply Diagnosed HIV-Positive Homeless Populations initiative from 2012–2017, to provide coordinated housing supports and HIV, behavioral and mental health care to people experiencing homelessness. Nine funded demonstration sites created partnerships with housing providers, integrated behavioral health and HIV care, and provided intensive patient navigator services. A multi-demonstration site evaluation found that, compared to baseline, participants were more likely to be virally suppressed after 12 months in the intervention.Resource from the RWHAP Best Practices Compilation updated on 11/13/2023
-
SPNS Initiative: Accelerating Implementation of Long-Acting Injectables (2022-2026)
-
HIV Clinical Pharmacist Services
The HIV Clinical Pharmacist Services intervention shortens the time between referral to and engagement in care by allowing newly referred clients to see pharmacists in addition to other clinical providers for their initial appointment. This intervention is supported by findings from a retrospective cohort study that took place from 2013 to 2017 at a RWHAP-funded clinic. In addition to significantly decreasing the time between referral and initial visit, clients who saw a pharmacist also experienced shortened time to antiretroviral therapy initiation and viral suppression compared to those who only saw non-pharmacist providers.Resource from the RWHAP Best Practices Compilation updated on 11/01/2023
-
Simplifying Salvage Antiretroviral Regimens in Treatment-Experienced PLWH
In a single-center restrospective cohort study, patients with extensive treatment experience and history of virologic failure and multi-drug resistance underwent simplification of ARV salvage regimens with a median pill burden reduction of six pills per day. This strategy led to high rates of virologic suppression.
Resource (Conference Presentation) updated 09/14/2023
-
HIV Clinic Staff and Community Perspectives on Long-Acting Injectable ART in New York City
The first long-acting injectable antiretroviral therapy (LAI ART) formulation was FDA-approved January 2021. Drawing on the Consolidated Framework on Implementation Research, this mixed methods study assessed knowledge, attitudes, practices, and perceived barriers and facilitators related to implementation of LAI ART in NYC among HIV clinic staff and people with HIV.
Resource (Conference Presentation) updated 09/14/2023
-
Applying technological innovation: Harnessing an electronic patient portal to achieve a patient-centered approach to recertification
Using a multidisciplinary approach to harness the electronic patient portal for completion of RWHAP six-month recertification documents, we were able to create a more patient-centered method that complies with program requirements. We will discuss the challenges, opportunities, and results of using such technology in program recertification.
Resource (Conference Presentation) updated 09/14/2023
-
Promising Practices: The Impact of COVID-19 Related Policy Changes On Enrollment Capacity Within California's ADAP
California’s AIDS Drug Assistance Program (ADAP) and Pre-Exposure Prophylaxis Assistance Program (PrEP-AP) provide access to life-saving medications and insurance assistance for eligible California residents living with or at risk of acquiring HIV. This presentation will explore the efficacy of various program policy changes implemented by California during the COVID-19 pandemic.
Resource (Conference Presentation) updated 09/14/2023
-
Assessing Medication Access Barriers in Patients Living with HIV
Virginia quality improvement program that identifies access to medication barriers and provides emergency medication supplies to people with HIV if no timely access is secured.
Resource (Conference Presentation) updated 09/14/2023
-
Long-Acting HIV Treatment Demonstrates Efficacy in People with Challenges Taking Daily Medicine as Prescribed
Long-acting antiretroviral therapy (ART) with cabotegravir and rilpivirine was superior in suppressing HIV replication compared to daily oral ART in people who had been unable to maintain viral suppression through an oral daily regimen.News Article updated on 02/28/2024 -
Rapid ART Program Initiative for New Diagnoses
Rapid ART Program Initiative for New Diagnoses (RAPID) was designed to connect people with a new HIV diagnosis to ART within five days of diagnosis and within one day of their initial care visit. Linkage navigators counseled people on HIV care, identified an available clinician capable of immediately prescribing ART, scheduled the clinical appointment, and connected people to additional support services. RAPID led to a reduction in median time between initial diagnosis and both ART initiation and viral suppression.Resource from the RWHAP Best Practices Compilation updated on 03/19/2024
-
National HIV PrEP Curriculum
Online learning portal for clinicians on pre-exposure prophylaxis (PrEP) for prevention of HIV.Resource updated 03/13/2024
-
340B Drug Pricing Program
Information on HRSA's Office of Pharmacy Affairs, which administers the 340b program, which provides drug discounts to certain federal grantees,
Resource updated 09/20/2023
-
Clinical Info HIV.gov
U.S. HIV-related treatment guidelines, drug database, and glossary.
Resource updated 09/20/2023
-
National Clinician Consultation Center
Healthcare providers can receive no-cost expert clinical consultation in HIV prevention & care, HCV treatment, and substance use management.
Resource updated 09/20/2023